Department of Cardio-thoracic surgery, Erasmus University Medical Center, Rotterdam, Netherlands.
EUROMACS, EACTS House, Windsor, United Kingdom.
Eur J Cardiothorac Surg. 2023 Aug 1;64(2). doi: 10.1093/ejcts/ezad263.
A small percentage of paediatric patients supported with a ventricular assist device (VAD) can have their device explanted following myocardial recovery. The goal of this systematic review is to summarize the current literature on the clinical course in these children after weaning.
A systematic literature search was performed on 27 May 2022 using Embase, Medline ALL, Web of Science Core Collection, Cochrane Central Register of Controlled Trials and Google Scholar to include all literature on paediatric patients supported by a durable VAD during the last decade. Overlapping study cohorts and registry-based studies were filtered out.
Thirty-seven articles were included. Eighteen of them reported on the incidence of recovery in cohort studies, with an overall incidence rate of 8.7% (81/928). Twenty-two of the included articles reported on clinical outcomes after VAD explantation (83 patients). The aetiologies varied widely and were not limited to diseases with a natural transient course like myocarditis. Most of the patients in the included studies (70; 84.3%) were supported by a Berlin Heart EXCOR, and in 66.3% (55/83), only the left ventricle had to be supported. The longest follow-up period was 19.1 years, and multiple studies reported on long-term myocardial recovery. Fewer than half of the reported deaths had a cardiac cause.
Myocardial recovery during VAD support is dependent on various contributing components. The interactions among patient-, device-, time- and hospital-related factors are complex and not yet fully understood. Long-term recovery after VAD support is achievable, even after a long duration of VAD support, and even in patients with aetiologies different from myocarditis or post-cardiotomy heart failure. More research is needed on this favourable outcome after VAD support.
一小部分接受心室辅助装置(VAD)支持的儿科患者在心肌恢复后可以将其装置取出。本系统评价的目的是总结这些患者脱机后的临床过程的现有文献。
2022 年 5 月 27 日,我们通过 Embase、Medline ALL、Web of Science 核心合集、Cochrane 对照试验中心注册库和 Google Scholar 进行了系统的文献检索,纳入了过去十年中所有使用耐用性 VAD 支持的儿科患者的文献。排除了重叠的研究队列和基于注册的研究。
共纳入 37 篇文章。其中 18 篇报道了队列研究中恢复的发生率,总发生率为 8.7%(81/928)。纳入的 22 篇文章报道了 VAD 取出后的临床结局(83 例患者)。病因广泛,不仅限于心肌炎等具有自然短暂病程的疾病。纳入研究的大多数患者(70;84.3%)接受柏林心脏 EXCOR 支持,在 66.3%(55/83)的患者中,只有左心室需要支持。最长的随访时间为 19.1 年,多项研究报告了长期心肌恢复。报告的死亡人数中不到一半有心脏原因。
VAD 支持期间的心肌恢复取决于各种相关因素。患者、设备、时间和医院相关因素之间的相互作用很复杂,尚未完全了解。VAD 支持后长期恢复是可能的,即使 VAD 支持时间很长,甚至在病因与心肌炎或心脏手术后心力衰竭不同的患者中也是如此。需要对 VAD 支持后的这种有利结局进行更多的研究。